Search Results - Michael Gregor

Refine Results
  1. 1
    Characteristics of spinal neurones responding to cutaneous myelinated and unmyelinated fibres*

    Characteristics of spinal neurones responding to cutaneous myelinated and unmyelinated fibres* by Michael Gregor, M. Zimmermann

    Published 1972
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Determinants of Life Satisfaction in Inflammatory Bowel Disease

    Determinants of Life Satisfaction in Inflammatory Bowel Disease by Karl-Heinz Janke, Bodo Klump, Michael Gregor, Christoph Meisner, Winfried Haeuser

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Rituximab in the treatment of polyneuropathy associated with anti‐MAG antibodies

    Rituximab in the treatment of polyneuropathy associated with anti‐MAG antibodies by Susanne Renaud, Michael Gregor, Peter Fuhr, Delia Lorenz, Günther Deuschl, Aloïs Gratwohl, Andreas Steck

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The Adapter Protein Apoptotic Protease-activating Factor-1 (Apaf-1) Is Proteolytically Processed during Apoptosis

    The Adapter Protein Apoptotic Protease-activating Factor-1 (Apaf-1) Is Proteolytically Processed during Apoptosis by Kirsten Lauber, Helga A.E. Appel, Stephan Schlösser, Michael Gregor, Klaus Schulze‐Osthoff, Sebastian Wesselborg

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Quality of Life after Flap Reconstruction of the Distal Lower Extremity: Is There a Difference Between a Pedicled Suralis Flap and a Free Anterior Lateral Thigh Flap?

    Quality of Life after Flap Reconstruction of the Distal Lower Extremity: Is There a Difference Between a Pedicled Suralis Flap and a Free Anterior Lateral Thigh Flap? by Schmidt, Karsten, Jakubietz, Michael Gregor, Gilbert, Fabian, Hausknecht, Franca, Meffert, Rainer Heribert, Jakubietz, Rafael Gregor

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL

    HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL by Anita Pathil, Sorin Armeanu, Sascha Venturelli, Paolo Mascagni, Thomas S. Weiß, Michael Gregor, Ulrich M. Lauer, Michael Bitzer

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Development of Intestinal Regulatory Peptides in the Human Fetus

    Development of Intestinal Regulatory Peptides in the Human Fetus by M G Bryant, A.M.J. Buchan, Michael Gregor, Mohammad A. Ghatei, J. M. Polak, Stephen R. Bloom

    Published 1982
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Gut hormones in tropical malabsorption.

    Gut hormones in tropical malabsorption. by H S Besterman, Guillermo Cook, D. L. Sarson, N.D. Christofides, M G Bryant, Michael Gregor, S.R. Bloom

    Published 1979
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib

    Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib by Marius Horger, Ulrich M. Lauer, Christina Schraml, Christoph P. Berg, Ursula Koppenhöfer, Claus D. Claussen, Michael Gregor, Michael Bitzer

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Sendai Virus Infection Induces Apoptosis through Activation of Caspase-8 (FLICE) and Caspase-3 (CPP32)

    Sendai Virus Infection Induces Apoptosis through Activation of Caspase-8 (FLICE) and Caspase-3 (CPP32) by Michael Bitzer, Florian Prinz, Manuel Bauer, Martin Spiegel, Wolfgang J. Neubert, Michael Gregor, Klaus Schulze‐Osthoff, Ulrich M. Lauer

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A functional CFTR protein is required for mouse intestinal cAMP‐, cGMP‐ and Ca<sup>2+</sup>‐dependent HCO<sub>3</sub><sup>−</sup> secretion

    A functional CFTR protein is required for mouse intestinal cAMP‐, cGMP‐ and Ca<sup>2+</sup>‐dependent HCO<sub>3</sub><sup>−</sup> secretion by Ursula Seidler, Irina Blumenstein, Alexandra Kretz, D. Viellard‐Baron, Heidi Rossmann, William H Colledge, Martin Evans, R. Ratcliff, Michael Gregor

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Down-regulated in adenoma mediates apical Cl−/HCO3− exchange in rabbit, rat, and human duodenum

    Down-regulated in adenoma mediates apical Cl−/HCO3− exchange in rabbit, rat, and human duodenum by Petra Jacob, Heidi Rossmann, Georg Lamprecht, Alexandra Kretz, Christina Neff, Elena Lin–Wu, Michael Gregor, David A. Groneberg, Juha Kere, Ursula Seidler

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Epigenetic combination therapy as a tumor‐selective treatment approach for hepatocellular carcinoma

    Epigenetic combination therapy as a tumor‐selective treatment approach for hepatocellular carcinoma by Sascha Venturelli, Sorin Armeanu, Anita Pathil, Chih‐Jen Hsieh, Thomas S. Weiß, Reinhard Vonthein, Manfred Wehrmann, Michael Gregor, Ulrich M. Lauer, Michael Bitzer

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

    Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial by Oliver Nehls, Helmut Oettle, J. T. Hartmann, R. D. Hofheinz, H G Hass, Marius Horger, Ursula Koppenhöfer, Andreas Hochhaus, Jens Stieler, Jörg Trojan, Michael Gregor, Bodo Klump

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Barbara Eichhorst, Tadeusz Robak, Emili Montserrat, Paolo Ghia, Carsten Utoft Niemann, Arnon P. Kater, Michael Gregor, Florence Cymbalista, Christian Buske, Peter Hillmen, Michael Hallek, Ulrich Mey

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial

    Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial by Verena Gotta, Nicolas Widmer, Laurent A. Décosterd, Yves Chalandon, Dominik Heim, Michael Gregor, Rudolf Benz, L. Leoncini-Franscini, Gabriela M. Baerlocher, Michel A. Duchosal, Chantal Csajka, Thierry Buclin

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX

    Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapo... by Oliver Nehls, T. Okech, C-J Hsieh, T Enzinger, Mario Sarbia, F Borchard, H. H. Gruenagel, V. Gaco, Holger G. Hass, Hendrik‐Tobias Arkenau, J. T. Hartmann, Rainer Porschen, Michael Gregor, Bodo Klump

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Ibrutinib Lead-in followed by Venetoclax Plus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia - SAKK 34/17

    Ibrutinib Lead-in followed by Venetoclax Plus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia - SAKK 34/17 by Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich, Katia Pini, Georg Stüssi, Gisela Müller, Nathan Cantoni, Richard Cathomas, Ulrich Mey, Anouk Widmer, Thorsten Zenz, Michael Gregor, Dominik Heim, Martin Andres, Rudolf Benz, Davide Rossi

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis

    Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis by Matthias Schwab, Elke Schaeffeler, Claudia Marx, Martin F. Fromm, Bernd Kaskas, Joerg Metzler, Eduard F. Stange, Hans Herfarth, Juergen Schöelmerich, Michael Gregor, S. Walker, Ingolf Cascorbi, Ivar Roots, Ulrich Brinkmann, Ulrich M. Zanger, Michel Eichelbaum

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Cytarabine Dose for Acute Myeloid Leukemia

    Cytarabine Dose for Acute Myeloid Leukemia by Bob Löwenberg, Thomas Pabst, Edo Vellenga, Wim van Putten, Harry C. Schouten, Carlos Graux, Augustin Ferrant, Pieter Sonneveld, Bart J. Biemond, Aloïs Gratwohl, Georgine E. de Greef, Leo F. Verdonck, M Schaafsma, Michael Gregor, Matthias Theobald, Urs Schanz, Johan Maertens, Gert J. Ossenkoppele

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: